Clinical Trials Logo

Nerve Pain clinical trials

View clinical trials related to Nerve Pain.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05313217 Completed - Nerve Pain Clinical Trials

Spine Position and Neural Sensitivity

Start date: March 28, 2022
Phase: N/A
Study type: Interventional

The purpose of this research study is to see if there is a relationship between the tightness of the hamstring muscles (muscles on the back of the thighs), reported sensations related to stretch of the nerves of the lower extremity, and different positions of participants' backs. We will investigate the qualitative differences as provided verbally by participants (sensation felt at maximum knee extension angle) and quantitative differences as provided by surface electromyographic (EMG) measurements of hamstring activity and inclinometer measures of the knee angle.

NCT ID: NCT05289427 Completed - Knee Disease Clinical Trials

Triple Injection Peri-sartorius (TIPS) Block

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

Comparison between the pain scores after total knee arthroplasty in patients receiving triple injection peri-sartorius (TIPS) block versus femoral nerve block (FNB)

NCT ID: NCT04688814 Completed - Pain, Postoperative Clinical Trials

SEQ Block for Perioperative Analgesia in Acetabular Surgery

Start date: December 25, 2020
Phase: Phase 3
Study type: Interventional

The study will evaluate ultrasound guided SEQ block: single puncture combined lumbar erector spinae plane block and paraspinous sagittal shift (PSSS) quadratus lumborum block when compared with conventional intravenous morphine analgesia in patients undergoing posterior column acetabular fracture surgery

NCT ID: NCT03305666 Completed - Pneumonia Clinical Trials

Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures

Start date: October 5, 2017
Phase: Phase 4
Study type: Interventional

Rib fractures represent a common injury pattern this is highly associated with patient morbidity and mortality, as pain control remains a challenge. Even after surgical stabilization of rib fractures (SSRF), unsuccessful pain control can lead to morbid outcomes such as pneumonia and opioid dependence. Multi-modal anesthesia, with the use of thoracic epidurals and para-vertebral injections/catheters, has shown to lessen these occurrences but are subject to a wide array of limitations. A more directed therapy with liposomal bupivacaine has shown to provide sustained analgesia for up to 72 hours in patients who have undergone other types of thoracic surgery, but not SSRF. The hypothesis of the current clinical trial is that, among patients undergoing SSRF, liposomal bupivacaine delivered via video assisted thoracic surgery (VATS) is an intercostal nerve block that provides comparable analgesia to the pain catheter, as measured by pulmonary function, numeric pain scoring, and postoperative narcotic use.

NCT ID: NCT03160937 Completed - Movement Disorders Clinical Trials

Neurodynamic Mobilization and Foam Rolling

Start date: January 10, 2017
Phase: N/A
Study type: Interventional

The purpose of this study was to assess the acute effects of a single NM treatment session on DOMS and to compare them with those of one foam roller (FR) session. Following the damaging plyometric exercise bout, the participants were randomly assigned in a counter-balanced fashion to either a FR or NM treatment group; treatments were administered 48-h post-exercise. The dependent variables were recorded before the exercise, 48-h post-exercise before treatment, and immediately post-treatment.

NCT ID: NCT03121976 Completed - Pain Clinical Trials

A Comparison of US and Evoked Motor Response-guided Placement of Continuous Femoral Nerve Block Following TKA

Start date: January 2, 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine which technique for catheter placement in continuous femoral nerve block (FNB) is most successful - guidance with (1) ultrasound or (2) nerve stimulation and ultrasound. Sensory and motor assessment scores will be obtained post-FNB. Patient controlled analgesia and opiate consumption is also recorded along with pain scores for the first 48 hour post-FNB.

NCT ID: NCT02927951 Completed - Clinical trials for Diabetic Peripheral Neuropathy

The Effect of Pregabalin on Pain Related to Walking in Patients With Diabetic Peripheral Neuropathy

Start date: January 2011
Phase: Phase 3
Study type: Interventional

The hypothesis of this study is that pregabalin, 150 mg bid, will reduce general daytime pain in patients diagnosed with diabetic peripheral neuropathy and that it will also reduce the level of pain associated with walking. Consequently, it is hypothesized that the reduction in pain will result in an increase in the amount of walking they do during the day, improvements in their gait, balance, risk of falls and sleep patterns.

NCT ID: NCT02225054 Completed - Shoulder Pain Clinical Trials

The Effect of Dexmedetomidine on Brachial Plexus Block for Shoulder Surgery

DEX
Start date: May 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether a small dose of Dexmedetomidine, when given either intravenously or as part of the interscalene nerve block solution, prolongs pain relief following shoulder surgery compared to local anesthetic solution alone.

NCT ID: NCT01954199 Completed - Low Back Pain Clinical Trials

The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain

Start date: March 2015
Phase: N/A
Study type: Interventional

This study aims to verify if patients with nerve-related leg pain benefits from neurodynamic treatment over two weeks.

NCT ID: NCT01200524 Completed - Nerve Pain Clinical Trials

A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..

Start date: October 2010
Phase: Phase 2
Study type: Interventional

A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with posttraumatic neuralgia.